|Articles|July 1, 2019
- Pharmaceutical Executive-07-01-2019
- Volume 39
- Issue 7
Pharmaceutical Executive, July 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Creating an ‘Unbossed’ Environment in the Workplaceabout 7 years ago
Proposed Rebates Rule Raises Tough Questionsabout 7 years ago
Drug Formulary Decisions: Fixing a Broken Systemabout 7 years ago
The Feasibility of Patient Insights Before Launchabout 7 years ago
Compliance Disruptorsabout 7 years ago
Asia’s Complex Compliance Landscapeabout 7 years ago
European Pricing Talks: A lot of Smoke—or is it Fire?about 7 years ago
FDA Maps Pathway to More Accessible Biosimilarsabout 7 years ago
Top Trends, Takeaways from DIAabout 7 years ago
Pharma & Biotech: Financial Pulse-Check, OutlookAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration
2
Pharmaceutical Executive Daily: Amplitude Therapeutics Partners with Eli Lilly
3
Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb
4
When Drug Pricing Becomes Trade Policy
5